Indication

Citeline Clinical provides comprehensive real-time R&D intelligence to the life sciences industry, and features an unmatched data collection of global clinical trials, vetted investigators, trial sites and drug development pipelines. Our content is curated by the industry’s largest team of expert analysts, making Citeline Clinical an unparalleled source of R&D intelligence on the market.

Pharmaprojects

• 100,000+ total drug profiles
• 6,000+ drug profiles added per year
• 58,000+ data sources
• 19,600+ drugs in active development
• 3,700+ mechanisms
• 3,100+ targets
• 1,700+ diseases
• 600+ rare diseases

Trialtrove

Over half of all trials found in Trialtrove can not be found in ClinicalTrials.gov; data is constantly curated from over 58,000 unique sources and the number of sources per TA has increased by ~40% since 2015

The clinical trial record is further populated by our Analyst team using supplementary sources and enriched with custom tagging to classify and categorize patient segments, trial tags/attributes, outcomes and more.

• 430,000+ trials (phases I-IV)
• 58,000+ data sources
• 3,400+ patient segments
• 1,350+ endpoints
• 310+ diseases across 9 therapeutic areas
• 200+ countries in all geographic areas

The Indication data product provides a comprehensive dataset for evaluating and analyzing the clinical trial competitive landscape and trial details within a particular disease. It encompasses the most relevant data points from the Pharmaprojects and Trialtrove data sources, offering valuable insights into various aspects of drug evaluation, clinical trials, and benchmarks. The scope of this dataset looks at the past 5 years worth of data.

The following sets of data have been included in this listing:
Trials - By Therapeutic Area, Disease, Patient Segment
Trials - Details by Phase, Status, and Benchmarks for Sites/Patients
Trials - By Country/Region
Trials - By Drug
Trials - By Sponsors
Trials - By Tags/Attributes
Trials - By Outcomes
Trials - By Study Design Attributes
Trials - by Primary Endpoints
Trials - Benchmarks by Patients per Site per Month per Sponsor
Trials - Benchmarks by Patients per Site per Month per Disease
Trials - Benchmark Sites per Country
Drugs - By Company, Status
Drugs - By Mechanism of Action
Drugs - By Biological Target
Drugs - By Therapeutic Class
Disease - By ICD10 Codes

You can use this data to analyze trends, make predictions, and inform your decision-making process in the pharmaceutical industry.

Once you subscribe to this listing, you will have access to all the data tables required.
Workflow:
• Consumer clicks Request button on Citeline listing.
• Citeline will reach out to the consumer and finalize terms.
• Citeline shares the data product with the consumer via Snowflake shares.

Additional Information This data product is updated regularly to ensure that you have the most recent and accurate information. If you have any questions or need further information, please don’t hesitate to contact us.